← Back to catalogue

Thyblate™

FDA UDI

Class II (US FDA UDI)

by RF Medical Co., Ltd.

Identity

Trade Name
THYBLATE™ FDA UDI
Generic Name
Percutaneous radio-frequency ablation probe, tumour-ablation, monopolar FDA UDI
Model / Reference
RFTSP 1007N FDA UDI

Identifiers

Primary DI / UDI-DI
08800142923722 FDA UDI
510(k) Number
K180999 FDA UDI
FDA Product Code
GEI FDA UDI
GMDN Term
Percutaneous radio-frequency ablation probe, tumour-ablation, monopolar FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
878.4400 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Percutaneous radio-frequency ablation probe, tumour-ablation, monopolar

Thyblate™ by RF Medical Co., Ltd. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Percutaneous radio-frequency ablation probe, tumour-ablation, monopolar.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 4b4fed3f-d105-447e-a915-1c59fa101b78 33 fields · synced Jun 1, 2026